MNOV
MediciNova, Inc.
Biotechnology · Healthcare · United States
1.40
close · 2026-10-30
value
37
cheaper than peers37
quality
89
stronger fundamentals89
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.85× | 73 |
| earnings yield, 2 years ago | -12.1% | 56 |
| earnings yield, 1 year ago | -16.4% | 50 |
| cash flow yield, 2 years ago | -10.8% | 46 |
| earnings yield, latest year | -17.1% | 44 |
| cash flow yield, latest year | -14.2% | 43 |
| earnings yield, 3 years ago | -20.7% | 43 |
| cash flow yield, 1 year ago | -15.4% | 40 |
| cash flow yield, 3 years ago | -18.7% | 30 |
| price to sales | 74.86× | 16 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.3% | 98 |
| revenue growth | 240.6% | 85 |
| return on equity | -25.6% | 70 |
| operating margin | -554.3% | 31 |
4 of 4 measures available
Facts
| market cap | $69M |
| free cash flow | -$5.7M |
| employees | 6 |
| first trade | 2006-12-08 |
| next earnings | not reported |
| fundamentals updated | 2026-08-20 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.24 | -0.23 | -0.17 | -0.29 |
| free cash flow | -$9.8M | -$10.6M | -$7.5M | -$12.9M |
| net income | -$12.0M | -$11.0M | -$8.6M | -$14.1M |
| revenue | $409,657 | $0 | $1.0M | $0 |